This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Briscoe Law Firm Investigates Martek Biosciences For Shareholders

The Briscoe Law Firm, PLLC, founded by a former state prosecutor and enforcement attorney for the United States Securities and Exchange Commission, and the law firm of Powers Taylor LLP are investigating the fairness of the proposed acquisition of Martek Biosciences Corporation (“Martek Biosciences” or “MATK”) (NASDAQ: MATK) by Royal DSM N.V. (“DSM”) for shareholders. The investigation relates to possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Martek Biosciences for approving this transaction, whether Martek Biosciences’ Board of Directors acted in the shareholders’ best interests, and whether the transaction provides fair value and adequate disclosures to the shareholders.

The definitive acquisition agreement, which was announced on December 21, 2010, involves an all-cash tender offer valued at approximately $1.09 billion that is expected to commence in January 2011 and close in February 2011. Under the proposed acquisition, Martek Biosciences shareholders will receive a cash payment of only $31.50 for each share of Martek Biosciences/MATK common stock they hold. While the acquisition price reportedly represents an approximate 35% premium over Martek Biosciences’ closing price the day before the acquisition announcement, Martek Biosciences recently reported strong fourth quarter results, including a 36% increase in revenue growth, well above analysts’ estimates, and operational improvements. Based on this and other factors, the firms believe that the acquisition price significantly undervalues the company and may not be fair to Martek Biosciences shareholders.

If you currently own shares of Martek Biosciences/MATK and would like additional information regarding this investigation, or if you have information regarding the allegations involved in this transaction, please contact Patrick Powers at Powers Taylor LLP, toll free (877) 728-9607, via e-mail at patrick@powerstaylor.com, or Willie Briscoe at The Briscoe Law Firm, PLLC toll free (877) 397-5991, or via email at WBriscoe@TheBriscoeLawFirm.com. There is no cost or fee to you.

The Briscoe Law Firm is a full service business litigation and shareholder rights advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs